Share This Article:

IL-10 Gene Knockout Reduces the Expression of mGlu Receptor 1a/b and Decreases the Glutamate-Dependent Production of Nitric Oxide

Abstract Full-Text HTML XML Download Download as PDF (Size:3064KB) PP. 1019-1029
DOI: 10.4236/jbise.2014.713099    2,273 Downloads   2,663 Views   Citations


IL-10 provides trophic and survival effects directly on neurons, promotes axonal outgrowth, and stimulates neuroregeneration. In this study, we analyzed the activities of arginase and nitric oxide synthase (NOS) in synaptoneurosomes derived from brain cortex of C57BL/6 IL-10 gene-knockout (KO) and wild-type (Wt) mice and determined that the synaptoneurosomes derived from KO mice present lower arginase II activity and lower spermine content than those derived from Wt mice, whereas the basal NOS activity in the KO synaptoneurosomes was higher than that observed in the control synaptoneurosomes. Moreover, our results indicate that the plasma membranes isolated from the KO mice brain exhibit significantly lower spermine-induced enhancement of [3H] MK-801 binding than the plasma membranes from the brain of Wt mice. Glutamate increases the production of nitric oxide (NO) in Wt synaptoneurosomes in a dose-dependent manner, whereas in the KO synaptoneurosomes, this amino acid does not affect the synthesis of NO. The glutamate-dependent acceleration of NO synthesis in Wt synaptoneurosomes was abrogated by LY367385, an antagonist of mGluR1a/b. The western blot analysis of the synaptoneurosomal proteins demonstrates that the expression of the subunits of NMDAR (NMDAR2A and NMDAR2B), the level of NMDAR-bound nNOS and the expression of iNOS are not changed in KO mice and that only the level of mGluR1a/b is markedly reduced in the synaptoneurosomes of KO mice. We conclude that a neuroprotective and neuroregenerative property of IL-10, in addition to its effects on polyamine metabolism and the spermine-dependent modulation of NMDAR, may involve the regulation of mGluR1a/b expression.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Koriauli, S. , Barbakadze, T. , Natsvlishvili, N. , Dabrundashvili, N. , Kvaratskhelia, E. and Mikeladze, D. (2014) IL-10 Gene Knockout Reduces the Expression of mGlu Receptor 1a/b and Decreases the Glutamate-Dependent Production of Nitric Oxide. Journal of Biomedical Science and Engineering, 7, 1019-1029. doi: 10.4236/jbise.2014.713099.


[1] Grilli, M., Barbieri, I., Basudev, H., Brusa, R., Casati, C., Lozza, G. and Ongini, E. (2000) Interleukin-10 Modulates Neuronal Threshold of Vulnerability to Ischaemic Damage. European Journal of Neuroscience, 12, 2265-2272.
[2] Boyd, Z.S., Kriatchko, A., Yang, J., Agarwal, N., Wax, M.B. and Patil, R.V. (2003) Interleukin-10 Receptor Signaling through STAT-3 Regulates the Apoptosis of Retinal Ganglion Cells in Response to Stress. Investigative Ophthalmology & Visual Science, 44, 5206-5211.
[3] Zhou, Z., Peng, X., Insolera, R., Fink, D.J. and Mata, M. (2009) IL-10 Promotes Neuronal Survival Following Spinal Cord Injury. Experimental Neurology, 220, 183-190.
[4] Vidal, P.M., Lemmens, E., Dooley, D. and Hendrix, S. (2013) The Role of “Anti-Inflammatory” Cytokines in Axon Regeneration. Cytokine & Growth Factor Reviews, 24, 1-12.
[5] Zhou, Z., Peng, X., Insolera, R., Fink, D.J. and Mata, M. (2009) Interleukin-10 Provides Direct Trophic Support to Neurons. Journal of Neurochemistry, 110, 1617-1627.
[6] Lang, R., Patel, D., Morris, J.J., Rutschman, R.L. and Murray, P.J. (2002) Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10. The Journal of Immunology, 169, 2253-2263.
[7] Munder, M., Eichmann, K., Morán, J.M., Centeno, F., Soler, G. and Modolell, M. (1999) Th1/Th2-Regulated Expression of Arginase Isoforms in Murine Macrophages and Dendritic Cells. The Journal of Immunology, 163, 3771-3777.
[8] Chu, P.J., Saito, H. and Abe, K. (1995) Polyamines Promote Regeneration of Injured Axons of Cultured Rat Hippocampal Neurons. Brain Research, 673, 233-241.
[9] Williams, K. (1997) Interactions of Polyamines with Ion Channels. Biochemical Journal, 325, 289-297.
[10] Pellegrini-Giampietro, D.E. (2003) An Activity-Dependent Spermine-Mediated Mechanism That Modulates Glutamate Transmission. Trends in Neurosciences, 26, 9-11.
[11] Liu, P., Gupta, N., Jing, Y. and Zhang, H. (2008) Age-Related Changes in Polyamines in Memory-Associated Brain Structures in Rats. Neuroscience, 155, 789-796.
[12] Mori, M. and Gotoh, T. (2000) Regulation of Nitric Oxide Production by Arginine Metabolic Enzymes. Biochemical and Biophysical Research Communications, 275, 715-719.
[13] Estévez, A.G., Sahawneh, M.A., Lange, P.S., Bae, N., Egea, M. and Ratan, R.R. (2006) Arginase 1 Regulation of Nitric Oxide Production Is Key to Survival of Trophic Factor-Deprived Motor Neurons. The Journal of Neuroscience, 26, 8512-8516.
[14] Wiesinger, H. (2001) Arginine Metabolism and the Synthesis of Nitric Oxide in the Nervous System. Progress in Neurobiology, 64, 365-391.
[15] Lange, P.S., Langley, B., Lu, P. and Ratan, R.R. (2004) Novel Roles for Arginase in Cell Survival, Regeneration, and Translation in the Central Nervous System. Journal of Nutrition, 134, 2812S-2817S.
[16] Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J.W., Wang, Y.T., Salter, M.W. and Tymianski, M. (2002) Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor-PSD-95 Protein Interactions. Science, 298, 846-850.
[17] Wang, H. and Zhuo, M. (2012) Group I Metabotropic Glutamate Receptor-Mediated Gene Transcription and Implications for Synaptic Plasticity and Diseases. Frontiers in Pharmacology, 3, 189.
[18] Maiese, K., Vincent, A., Lin, S.H. and Shaw, T. (2000) Group I and Group III Metabotropic Glutamate Receptor Subtypes Provide Enhanced Neuroprotection. Journal of Neuroscience Research, 62, 257-272.
[19] Maiese, K., Chong, Z.Z. and Li, F. (2005) Driving Cellular Plasticity and Survival through the Signal Transduction Pathways of Metabotropic Glutamate Receptors. Current Neurovascular Research, 2, 425-446.
[20] Chen, T., Cao, L., Dong, W., Luo, P., Liu, W., Qu, Y. and Fei, Z. (2012) Protective Effects of mGluR5 Positive Modulators against Traumatic Neuronal Injury through PKC-Dependent Activation of MEK/ERK Pathway. Neurochemical Research, 37, 983-990.
[21] Byrnes, K.R., Loane, D.J. and Faden, A.I. (2009) Metabotropic Glutamate Receptors as Targets for Multipotential Treatment of Neurological Disorders. Neurotherapeutics, 6, 94-107.
[22] Hollingsworth, E.B., McNeal, E.T., Burton, J.L., Williams, R.J., Daly, J.W. and Creveling, C.R. (1985) Biochemical Characterization of a Filtered Synaptoneurosome Preparation from Guinea Pig Cerebral Cortex: Cyclic Adenosine 3’: 5’-Monophosphate-Generating Systems, Receptors, and Enzymes. Journal of Neuroscience, 5, 2240-2253.
[23] Weiler, I.J., Spangler, C.C., Klintsova, A.Y., Grossman, A.W., Kim, S.H., Bertaina-Anglade, V., Khaliq, H., de Vries, F.E., Lambers, F.A., Hatia, F., Base, C.K. and Greenough, W.T. (2004) Fragile X Mental Retardation Protein Is Necessary for Neurotransmitter-Activated Protein Translation at Synapses. Proceedings of the National Academy of Sciences of the United States of America, 101, 17504-17509.
[24] Benavides, J., Claustre, Y. and Scatton, B. (1988) L-Glutamate Increases Internal Free Calcium Levels in Synaptoneurosomes from Immature Rat Brain via Quisqualate Receptors. Journal of Neuroscience, 8, 3607-3615.
[25] Muddashetty, R.S., Kelic, S., Gross, C., Xu, M. and Bassell, G.J. (2007) Dysregulated Metabotropic Glutamate Receptor-Dependent Translation of AMPA Receptor and Postsynaptic Density-95 mRNAs at Synapses in a Mouse Model of Fragile X Syndrome. Journal of Neuroscience, 27, 5338-5348.
[26] Kim, S.H., Fraser, P.E., Westaway, D., St. George-Hyslop, P.H., Ehrlich, M.E. and Gandy, S. (2010) Group II Metabotropic Glutamate Receptor Stimulation Triggers Production and Release of Alzheimer’s Amyloid β42 from Isolated Intact Nerve Terminals. Journal of Neuroscience, 30, 3870-3875.
[27] Mesquita, A.R., Correia-Neves, M., Castroa, A.G.R., Vieira, P., Pedrosaa, J., Palhaa, J.A. and Sousaa, N. (2008) IL-10 Modulates Depressive-Like Behavior. Journal of Psychiatric Research, 43, 89-97.
[28] Xin, J., Wainwright, D.A., Mesnard, N.A., Serpe, C.J., Sanders, V.M. and Jones, K.J. (2011) IL-10 within the CNS Is Necessary for CD4+ T Cells to Mediate Neuroprotection. Brain, Behavior, and Immunity, 25, 820-829.
[29] Sethi, R., Chava, R.S., Bashir, S. and Castro, E.M. (2011) An Improved High Performance Liquid Chromatographic Method for Identification and Quantization of Polyamines as Benzoylated Derivatives. American Journal of Analytical Chemistry, 2, 456-469.
[30] Yu, H., Iyer, R.K., Kern, R.M., Rodriguez, W.I., Grody, W.W. and Cederbaum, S.D. (2001) Expression of Arginase Isozymes in Mouse Brain. Journal of Neuroscience Research, 66, 406-422.
[31] Rameau, G.A., Chiu, L.Y. and Ziff, E.B. (2003) NMDA Receptor Regulation of nNOS Phosphorylation and Induction of Neuron Death. Neurobiology of Aging, 24, 1123-1133.
[32] Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T. and Pin, J.P. (2011) Metabotropic Glutamate Receptors: From the Workbench to the Bedside. Neuropharmacology, 60, 1017-1041.
[33] Kelly, A., Lynch, A., Vereker, E., Nolan, Y., Queenan, P., Whittaker, E., O’Neill, L.A. and Lynch, M.A. (2001) The Anti-Inflammatory Cytokine, Interleukin (IL)-10, Blocks the Inhibitory Effect of IL-1β on Long Term Potentiation. A Role for JNK. The Journal of Biological Chemistry, 276, 45564-45572.
[34] Traynelis, S.F., Hartley, M. and Heinemann, S.F. (1995) Control of Proton Sensitivity of the NMDA Receptor by RNA Splicing and Polyamines. Science, 268, 873-876.
[35] Choi, Y.B., Tenneti, L., Le, D.A., Ortiz, J., Bai, G., Chen, H.S. and Lipton, S.A. (2000) Molecular Basis of NMDA Receptor-Coupled Ion Channel Modulation by S-Nitrosylation. Nature Neuroscience, 3, 15-21.
[36] Knoblach, S.M. and Faden, A.I. (1998) Interleukin-10 Improves Outcome and Alters Proinflammatory Cytokine Expression after Experimental Traumatic Brain Injury. Experimental Neurology, 153, 143-151.
[37] Sharma, S., Yang, B., Xi, X., Grotta, J.C., Aronowski, J. and Savitz, S.I. (2011) IL-10 Directly Protects Cortical Neurons by Activating PI-3 Kinase and STAT-3 Pathways. Brain Research, 1373, 189-194.
[38] Thompson, C.D., Zurko, J.C., Hanna, B.F., Hellenbrand, D.J. and Hanna, A. (2013) The Therapeutic Role of Interleukin-10 after Spinal Cord Injury. Journal of Neurotrauma, 30, 1311-1324.
[39] Perez-Asensio, F.J., Perpiná, U., Planas, A.M. and Pozas, E. (2013) Interleukin-10 Regulates Progenitor Differentiation and Modulates Neurogenesis in Adult Brain. Journal of Cell Science, 126, 4208-4219.
[40] Steinert, J.R., Chernova, T. and Forsythe, I.D. (2010) Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia. The Neuroscientist, 16, 435-452.
[41] Bhardwaj, A., Northington, F.J., Martin, L.J., Hanley, D.F., Traystma, R.J. and Koehler, R.C. (1997) Characterization of Metabotropic Glutamate Receptor-Mediated Nitric Oxide Production in Vivo. Journal of Cerebral Blood Flow & Metabolism, 17, 153-160.
[42] Llansola, M. and Felipo, V. (2010) Metabotropic Glutamate Receptor 5, but Not 1, Modulates NMDA Receptor-Mediated Activation of Neuronal Nitric Oxide Synthase. Neurochemistry International, 56, 535-554.
[43] Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., Ogden, K.K., Hansen, K.B., Yuan, H., Myers, S.J. and Dingledine, R. (2010) Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharmacological Reviews, 62, 405-496.
[44] Reynolds, I.J. and Miller, R.J. (1989) Ifenprodil Is a Novel Type of NMDA Receptor Antagonist: Interaction with Polyamines. Molecular Pharmacology, 36, 758-765.
[45] Sharma, T.A. and Reynolds, I.J. (1999) Characterization of the Effects of Polyamines on [125I]MK-801 Binding to Recombinant N-Methyl-D-Aspartate Receptors. Journal of Pharmacology and Experimental Therapeutics, 289, 1041-1047.
[46] O’Shea, J.J., Pesu, M., Borie, D.C. and Changelian, P.S. (2004) A New Modality for Immunosuppression: Targeting the JAK/STAT Pathway. Nature Reviews Drug Discovery, 3, 555-564.
[47] Sica, A. and Bronte, V. (2007) Altered Macrophage Differentiation and Immune Dysfunction in Tumor Development. Journal of Clinical Investigation, 117, 1155-1166.
[48] Gotoh, T., Chowdhury, S., Takiguchi, M. and Mori, M. (1997) The Glucocorticoid-Responsive Gene Cascade. Activation of the Rat Arginase Gene through Induction of C/EBPβ. The Journal of Biological Chemistry, 272, 3694-3698.
[49] Oliva Jr., A.A., Kang, Y., Sanchez-Molano, J., Furones, C. and Atkins, C.M. (2012) STAT3 Signaling after Brain Injury. Journal of Neurochemistry, 120, 710-720.
[50] Ramji, D.P. and Foka, P. (2002) CCAAT/Enhancer-Binding Proteins: Structure, Function and Regulation. Biochemical Journal, 365, 561-575.
[51] Crepaldi, L., Lackner, C., Corti, C. and Ferraguti, F. (2007) Transcriptional Activators and Repressors for the Neuron-specific Expression of a Metabotropic Glutamate Receptor. The Journal of Biological Chemistry, 282, 17877-17889.
[52] Kfoury, N. and Kapatos, G. (2009) Identification of Neuronal Target Genes for CCAAT/Enhancer Binding Proteins. Molecular and Cellular Neuroscience, 40, 313-327.
[53] Ferraguti, F., Crepaldi, L. and Nicoletti, F. (2008) Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives. Pharmacological Reviews, 60, 536-581.

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.